Viral replication and infectivity of monkeypox through semen

dc.contributor.author	Reda, A.
dc.contributor.author	Sah, R.
dc.contributor.author	Rodriguez-Morales, A.J.
dc.contributor.author	Shah, J.
dc.date.accessioned	2025-10-31T18:32:17Z
dc.date.available	2025-10-31T18:32:17Z
dc.date.issued	2022
dc.identifier.uri	https://hdl.handle.net/20.500.12805/4570
dc.description.abstract	Given the activity of bebtelovimab against current global circulating SARS-CoV-2 variants, Hentzien and colleagues1 raise several questions as to why bebtelovimab is unavailable outside the USA.	en_US
dc.format	application/pdf
dc.language.iso	eng
dc.publisher	Elsevier
dc.relation.ispartof	urn:issn:1474-4457
dc.rights	https://purl.org/coar/access_right/c_abf2
dc.rights.uri	https://creativecommons.org/licenses/by-nc-sa/4.0/
dc.subject	Vaccination Strategies Against Emerging Viral Threats	en_US
dc.subject	Monkeypox Virus Dynamics and Public Health Response	en_US
dc.title	Viral replication and infectivity of monkeypox through semen	en_US
dc.type	https://purl.org/coar/resource_type/c_0857
dc.identifier.doi	https://doi.org/10.1016/S1473-3099(22)00611-9
dc.subject.ocde	https://purl.org/pe-repo/ocde/ford#3.03.08
dc.type.other	Communication letter o Case Report
dc.identifier.journal	The Lancet Infectious Diseases
dc.type.version	https://purl.org/coar/version/c_970fb48d4fbd8a85

Except where otherwise noted, this item's license is described as https://purl.org/coar/access_right/c_abf2